Sodium-glucose cotransporter-2 inhibitor therapy in kidney transplant patients with type 2 or post-transplant diabetes: an observational multicentre study.
腎移植患者合併2型糖尿病或移植後糖尿病的腎臟葡萄糖共轉運輸蛋白2抑制劑治療:一項觀察性多中心研究。
Clin Kidney J 2023-06-04
Use of Sodium-Glucose Cotransporter-2 Inhibitor for Diabetes Management in Patients Following Kidney Transplantation.
腎移植後糖尿病患者管理中鈉葡萄糖共轉運輸蛋白2抑製劑的應用。
J Pharm Technol 2023-06-19
Sodium-Glucose Cotransporter-2 Inhibitors After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Population-Based Investigation.
急性心肌梗塞後2型糖尿病患者使用鈉葡萄糖共同轉運蛋白2抑制劑:一項基於人口的研究。
J Am Heart Assoc 2023-08-01
Safety and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Solid Organ Transplant Recipients.
固體器官移植接受者中鈉葡萄糖共轉運輸蛋白-2抑制劑的安全性和有效性。
Prog Transplant 2023-10-11
SGLT2 inhibitors in diabetic and non-diabetic kidney transplant recipients: current knowledge and expectations.
糖尿病和非糖尿病腎移植接受者中SGLT2抑制劑:目前知識和期望。
Front Nephrol 2024-04-30
The efficacy and safety of sodium-glucose cotransporter-2 inhibitors in solid organ transplant recipients: A scoping review.
固體器官移植接受者中鈉葡萄糖共轉運輸蛋白-2抑制劑的療效和安全性:一項概覽性回顧。
Pharmacotherapy 2024-05-22
Exploring the mortality and cardiovascular outcomes with SGLT-2 inhibitors in patients with T2DM at dialysis commencement: a health global federated network analysis.
在透析開始時探討 SGLT-2 抑制劑對 T2DM 患者的死亡率和心血管結果:一項健康全球聯合網絡分析。
Cardiovasc Diabetol 2024-09-03